The treatment of severe malaria.
In the SEAQUAMAT trial, parenteral artesunate was shown to be associated with a considerably lower mortality than quinine, and is now the recommended treatment for severe malaria in low-transmission areas and in the second and third trimesters of pregnancy. A trial is underway to establish its role...
Главные авторы: | Dondorp, A, Day, N |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
2007
|
Схожие документы
-
The management of patients with severe malaria.
по: Day, N, и др.
Опубликовано: (2007) -
The treatment of severe malaria
по: Dondorp, A
Опубликовано: (2007) -
UK recommendations for severe malaria are worrying.
по: White, N, и др.
Опубликовано: (2007) -
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial.
по: Dondorp, A, и др.
Опубликовано: (2005) -
Malaria treatment in the United States.
по: Hanson, J, и др.
Опубликовано: (2007)